Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cloudflare, Inc.NET · Entity 2910 | Director | May 11, 2022 | May 12, 2022 |
| DoorDash, Inc.DASH · Entity 1541 | Director | May 24, 2023 | May 26, 2023 |
| Guardant Health, Inc.GH · Entity 3238 | Director | June 15, 2022 | June 17, 2022 |
| Palo Alto Networks IncPANW · Entity 1811 | Director | December 04, 2018 | December 06, 2018 |
| Snap IncSNAP · Entity 3584 | Director | July 20, 2022 | July 22, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cloudflare, Inc.
Report date May 11, 2022 · Filed May 12, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 2,441 |
Ending reported balance
After 2022-05-11 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2022-05-11 · Conversion · Acquired 11,000 · Balance 13,441 F1: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. Row 2 · 2022-05-11 · Sale · Disposed 5,000 · Balance 8,441 F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2021. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.08 to $55.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4. Row 3 · 2022-05-11 · Sale · Disposed 3,225 · Balance 5,216 F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2021. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.08 to $57.06, inclusive. Row 4 · 2022-05-11 · Sale · Disposed 1,000 · Balance 4,216 F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2021. F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.10 to $57.98, inclusive. Row 5 · 2022-05-11 · Sale · Disposed 1,200 · Balance 3,016 F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2021. F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.21 to $58.93, inclusive. Row 6 · 2022-05-11 · Sale · Disposed 575 · Balance 2,441 F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2021. F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.83 to $59.98, inclusive. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.56 · Expires 2028-12-12 | Direct | 33,000 |
Reported balance
After 2022-05-11 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-05-11 · Exercise / conversion · Disposed 11,000 · Balance 33,000 F8: The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 16 equal quarterly installments following December 13, 2018. F1: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. |
| Class B Common StockSEC Table II · derivative / convertible security | Direct | 11,000 |
Reported balance
After 2022-05-11 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-05-11 · Exercise / conversion · Acquired 11,000 · Balance 11,000 F1: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. |
| Class B Common StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-11 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-05-11 · Conversion · Disposed 11,000 · Balance 0 F1: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date.
F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2021.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.08 to $55.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.08 to $57.06, inclusive.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.10 to $57.98, inclusive.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.21 to $58.93, inclusive.
F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.83 to $59.98, inclusive.
F8: The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 16 equal quarterly installments following December 13, 2018.
DoorDash, Inc.
Report date May 24, 2023 · Filed May 26, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 3,557 |
Reported balance
After 2023-05-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-05-24 · Sale · Disposed 3,846 · Balance 3,557 F1: The sale reported by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2022. F2: These securities are represented by restricted stock units. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,100 |
Reported balance
Holding disclosure · report date 2023-05-24 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,100 F3: Shares are held by the Meresman Family Trust for which the Reporting Person and his spouse serve as trustees. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2022.
F2: These securities are represented by restricted stock units.
F3: Shares are held by the Meresman Family Trust for which the Reporting Person and his spouse serve as trustees.
Guardant Health, Inc.
Report date June 15, 2022 · Filed June 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON STOCKSEC Table I · non-derivative | Direct | 5,873 |
Reported balance
After 2022-06-15 transaction · row 1
1 source rowRow 1 · 2022-06-15 · Exercise / conversion · Acquired 1,814 · Balance 5,873 |
| RESTRICTED STOCK UNITSSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2022-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-06-15 · Exercise / conversion · Disposed 1,814 · Balance 0 F1: The Restricted Stock Units vest in full on the one-year anniversary of the grant date, June 15th, 2022. F2: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units vest in full on the one-year anniversary of the grant date, June 15th, 2022.
F2: Not applicable for Restricted Stock Units.
Palo Alto Networks Inc
Report date December 04, 2018 · Filed December 06, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2018-12-04 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2018-12-04 · Sale · Disposed 300 · Balance 1,658 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2: This sale price represents the weighted average sale price of the shares sold ranging from $175.45 to $176.41 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Row 2 · 2018-12-04 · Sale · Disposed 858 · Balance 800 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3: This sale price represents the weighted average sale price of the shares sold ranging from $176.63 to $177.53 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Row 3 · 2018-12-04 · Sale · Disposed 600 · Balance 200 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4: This sale price represents the weighted average sale price of the shares sold ranging from $177.97 to $178.77 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Row 4 · 2018-12-04 · Sale · Disposed 200 · Balance 0 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5: This sale price represents the weighted average sale price of the shares sold ranging from $179.22 to $179.24 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2: This sale price represents the weighted average sale price of the shares sold ranging from $175.45 to $176.41 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3: This sale price represents the weighted average sale price of the shares sold ranging from $176.63 to $177.53 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4: This sale price represents the weighted average sale price of the shares sold ranging from $177.97 to $178.77 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5: This sale price represents the weighted average sale price of the shares sold ranging from $179.22 to $179.24 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Snap Inc
Report date July 20, 2022 · Filed July 22, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 36,059 |
Reported balance
After 2022-07-20 transaction · row 1
1 source rowRow 1 · 2022-07-20 · Grant · Acquired 9,114 · Balance 36,059 F1: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock. 100% of the RSUs shall vest after the reporting person completes one year of continuous service from July 20, 2022. The RSUs will be subject to pro-rata acceleration upon the reporting person's discontinued service on the Issuer's board of directors and automatic full acceleration in the event of a change in control, as defined in the Issuer's 2017 Equity Incentive Plan. If the reporting person dies while in continuous service, 100% of the RSUs will be deemed fully vested immediately. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.03 · Expires 2032-07-19 | Direct | 65,553 |
Reported balance
After 2022-07-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-07-20 · Grant · Acquired 14,864 · Balance 65,553 F2: 100% of the shares subject to the option will vest upon the reporting person's completion of one year of continuous service from July 20, 2022. The shares subject to the option will be subject to pro-rata acceleration upon the reporting person's discontinued service on the Issuer's board of directors and automatic full acceleration in the event of a change in control, as defined in the Issuer's 2017 Equity Incentive Plan. If the reporting person dies while in continuous service, 100% of the shares subject to the option will be deemed fully vested immediately. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock. 100% of the RSUs shall vest after the reporting person completes one year of continuous service from July 20, 2022. The RSUs will be subject to pro-rata acceleration upon the reporting person's discontinued service on the Issuer's board of directors and automatic full acceleration in the event of a change in control, as defined in the Issuer's 2017 Equity Incentive Plan. If the reporting person dies while in continuous service, 100% of the RSUs will be deemed fully vested immediately.
F2: 100% of the shares subject to the option will vest upon the reporting person's completion of one year of continuous service from July 20, 2022. The shares subject to the option will be subject to pro-rata acceleration upon the reporting person's discontinued service on the Issuer's board of directors and automatic full acceleration in the event of a change in control, as defined in the Issuer's 2017 Equity Incentive Plan. If the reporting person dies while in continuous service, 100% of the shares subject to the option will be deemed fully vested immediately.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
LINKEDIN CORP
Report date December 08, 2016 · Filed December 09, 2016
Section 16 reporting ended · disclosed 2016-12-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-12-08 transaction · row 1
1 source rowRow 1 · 2016-12-08 · Disposition to issuer · Disposed 1,550 · Balance 0 F1: The shares of Class A Common Stock were cancelled pursuant to the Agreement and Plan of Merger, dated June 11, 2016, between the Issuer, Microsoft Corporation and Liberty Merger Sub Inc. (the "Merger Agreement") in exchange for a cash payment of $196 per share (the "Merger Consideration"). The reported number represents restricted stock units granted on June 9, 2016 which were accelerated pursuant to the terms of Issuer's 2011 Equity Incentive Plan. F2: Disposed of pursuant to the Merger Agreement, in exchange for the Merger Consideration. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 0 |
Reported balance
After 2016-12-08 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2016-12-08 · Disposition to issuer · Disposed 3,374 · Balance 0 F3: The shares of Class A Common Stock were cancelled pursuant to the Merger Agreement in exchange for the Merger Consideration. F2: Disposed of pursuant to the Merger Agreement, in exchange for the Merger Consideration. F4: Shares held directly by Meresman Family Trust UDT dated September 13, 1989 for which the Reporting Person and his spouse serve as trustees. |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee Footnote | 0 |
Reported balance
After 2016-12-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-12-08 · Disposition to issuer · Disposed 3,032 · Balance 0 F5: The shares of Class B Common Stock were cancelled pursuant to the Merger Agreement in exchange for the Merger Consideration and had no expiration date. F2: Disposed of pursuant to the Merger Agreement, in exchange for the Merger Consideration. F4: Shares held directly by Meresman Family Trust UDT dated September 13, 1989 for which the Reporting Person and his spouse serve as trustees. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $172.02 · Expires 2023-06-13 | Direct | 0 |
Reported balance
After 2016-12-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2016-12-08 · Disposition to issuer · Disposed 2,433 · Balance 0 F6: The stock option was granted on June 13, 2013 for 2,433 shares. 2,433 vested shares subject to the stock option were cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the stock option, multiplied by (y) the number of disposed option shares. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $202.50 · Expires 2024-08-04 | Direct | 0 |
Reported balance
After 2016-12-08 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2016-12-08 · Disposition to issuer · Disposed 1,560 · Balance 0 F7: The stock option was cancelled pursuant to the Merger Agreement, whereby the per share exercise price of the stock option is equal to or greater than the Merger Consideration. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $197.10 · Expires 2025-08-03 | Direct | 0 |
Reported balance
After 2016-12-08 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2016-12-08 · Disposition to issuer · Disposed 1,197 · Balance 0 F7: The stock option was cancelled pursuant to the Merger Agreement, whereby the per share exercise price of the stock option is equal to or greater than the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of Class A Common Stock were cancelled pursuant to the Agreement and Plan of Merger, dated June 11, 2016, between the Issuer, Microsoft Corporation and Liberty Merger Sub Inc. (the "Merger Agreement") in exchange for a cash payment of $196 per share (the "Merger Consideration"). The reported number represents restricted stock units granted on June 9, 2016 which were accelerated pursuant to the terms of Issuer's 2011 Equity Incentive Plan.
F2: Disposed of pursuant to the Merger Agreement, in exchange for the Merger Consideration.
F3: The shares of Class A Common Stock were cancelled pursuant to the Merger Agreement in exchange for the Merger Consideration.
F4: Shares held directly by Meresman Family Trust UDT dated September 13, 1989 for which the Reporting Person and his spouse serve as trustees.
F5: The shares of Class B Common Stock were cancelled pursuant to the Merger Agreement in exchange for the Merger Consideration and had no expiration date.
F6: The stock option was granted on June 13, 2013 for 2,433 shares. 2,433 vested shares subject to the stock option were cancelled pursuant to the Merger Agreement, in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the stock option, multiplied by (y) the number of disposed option shares.
F7: The stock option was cancelled pursuant to the Merger Agreement, whereby the per share exercise price of the stock option is equal to or greater than the Merger Consideration.
Medallia, Inc.
Report date October 29, 2021 · Filed November 02, 2021
Section 16 reporting ended · disclosed 2021-11-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2021-10-29 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-10-29 · Disposition to issuer · Disposed 22,782 · Balance 7,791 F1: Pursuant to the Agreement and Plan of Merger between the Issuer, Project Metal Parent, LLC and Project Metal Merger Sub, Inc. dated July 25, 2021, each share of issued and outstanding Issuer common stock was cancelled and converted into the right to receive $34.00 in cash. Row 2 · 2021-10-29 · Disposition to issuer · Disposed 7,791 · Balance 0 F2: The shares are represented by restricted stock units, or RSUs. Pursuant to the terms of the Issuer's 2019 Equity Incentive Plan and the Outside Director Compensation Plan, the RSUs vested in full in connection with a change in control. F3: Immediately prior to the effective time of the merger, each vested RSU was cancelled and converted into a right to receive $34.00 in cash for each outstanding unit. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger between the Issuer, Project Metal Parent, LLC and Project Metal Merger Sub, Inc. dated July 25, 2021, each share of issued and outstanding Issuer common stock was cancelled and converted into the right to receive $34.00 in cash.
F2: The shares are represented by restricted stock units, or RSUs. Pursuant to the terms of the Issuer's 2019 Equity Incentive Plan and the Outside Director Compensation Plan, the RSUs vested in full in connection with a change in control.
F3: Immediately prior to the effective time of the merger, each vested RSU was cancelled and converted into a right to receive $34.00 in cash for each outstanding unit.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2021 Filed Jun 21, 2021 17:25 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 1,814 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-21-000070 · wf-form4_162431073725829.xml · derivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,814 Underlying: COMMON STOCK · 1,814 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 16th, 2022. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 17:25 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 3,135 | $0.00 Strike: $117.19 | $0.00 |
DisclosureSEC source: 0001576280-21-000070 · wf-form4_162431073725829.xml · derivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,135 Underlying: COMMON STOCK · 3,135 shares Expires 2031-06-15 F1 · derivative.exercise_date: The stock option vests in full on the one-year anniversary of the grant date, June 16th, 2022. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 20:34 UTC | DoorDash, Inc. DASH · Entity 1541 | SaleClass A Common Stock | 15,967 | $145.08 | $2,316,492.36 |
DisclosureSEC source: 0001209191-21-039848 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,483 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $145.00 to $145.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · balance_after: Certain of these securities are represented by restricted stock units. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 17:02 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 4,934 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001576280-21-000066 · wf-form4_162370450964420.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,275 Underlying: COMMON STOCK · 4,934 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 17:02 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 4,934 | $113.60 | $560,502.40 |
DisclosureSEC source: 0001576280-21-000066 · wf-form4_162370450964420.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 17:02 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 4,934 | $5.94 | $29,307.96 |
DisclosureSEC source: 0001576280-21-000066 · wf-form4_162370450964420.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 22:57 UTC | Cloudflare, Inc. NET · Entity 2910 | GrantClass A Common Stock | 2,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038411 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,063 F1 · shares: Represents an automatic annual restricted stock unit, or RSU, award issued pursuant to the Issuer's Outside Director Compensation Policy. The RSUs vest on the earlier of (i) June 3, 2022 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 18:15 UTC | Medallia, Inc. MDLA · Entity 133980 | GrantCommon Stock | 7,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037385 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,627 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) May 28, 2022 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| May 18, 2021 Filed May 20, 2021 23:07 UTC | DoorDash, Inc. DASH · Entity 1541 | OtherClass A Common Stock | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034613 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,070 F1 · kind: Represents the receipt of shares of Class A Common Stock of the Issuer by virtue of the pro rata in-kind distribution by KPCB Digital Growth Fund II, LLC. F2 · ownership.nature: Shares are held by the Meresman Family Trust for which the Reporting Person and his spouse serve as trustees. Read SEC document |
| May 15, 2021 Filed May 18, 2021 20:18 UTC | Medallia, Inc. MDLA · Entity 133980 | GrantCommon Stock | 645 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033814 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,836 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, all of which were vested on the award date. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:40 UTC | Cloudflare, Inc. NET · Entity 2910 | ConversionClass B Common Stock · Derivative | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032156 · doc4.xml · derivative · entry 9 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 24,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:40 UTC | Cloudflare, Inc. NET · Entity 2910 | Exercise / conversionClass B Common Stock · Derivative | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032156 · doc4.xml · derivative · entry 8 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Class A Common Stock · 24,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:40 UTC | Cloudflare, Inc. NET · Entity 2910 | Exercise / conversionStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $8.56 | $0.00 |
DisclosureSEC source: 0001209191-21-032156 · doc4.xml · derivative · entry 7 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,000 Underlying: Class B Common Stock · 24,000 shares Expires 2028-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 16 equal quarterly installments following December 13, 2018. F1 · derivative.underlying: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:40 UTC | Cloudflare, Inc. NET · Entity 2910 | SaleClass A Common Stock | 968 | $69.21 | $66,996.64 |
DisclosureSEC source: 0001209191-21-032156 · doc4.xml · nonDerivative · entry 6 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,622 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.20 to $69.22,inclusive. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:40 UTC | Cloudflare, Inc. NET · Entity 2910 | SaleClass A Common Stock | 10,453 | $68.65 | $717,610.99 |
DisclosureSEC source: 0001209191-21-032156 · doc4.xml · nonDerivative · entry 5 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,590 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.20 to $69.13, inclusive. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:40 UTC | Cloudflare, Inc. NET · Entity 2910 | SaleClass A Common Stock | 5,297 | $67.89 | $359,617.04 |
DisclosureSEC source: 0001209191-21-032156 · doc4.xml · nonDerivative · entry 4 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,043 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.17 to $68.14, inclusive. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:40 UTC | Cloudflare, Inc. NET · Entity 2910 | SaleClass A Common Stock | 3,100 | $66.46 | $206,012.05 |
DisclosureSEC source: 0001209191-21-032156 · doc4.xml · nonDerivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,340 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.08 to $66.98, inclusive. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:40 UTC | Cloudflare, Inc. NET · Entity 2910 | SaleClass A Common Stock | 4,182 | $65.54 | $274,107.10 |
DisclosureSEC source: 0001209191-21-032156 · doc4.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,440 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4. Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:40 UTC | Cloudflare, Inc. NET · Entity 2910 | ConversionClass A Common Stock | 24,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-032156 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. Read SEC document |
| May 10, 2021 Filed May 12, 2021 17:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 4,934 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001576280-21-000064 · wf-form4_162085450202125.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,209 Underlying: COMMON STOCK · 4,934 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| May 10, 2021 Filed May 12, 2021 17:22 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 4,934 | $133.01 | $656,271.34 |
DisclosureSEC source: 0001576280-21-000064 · wf-form4_162085450202125.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 10, 2021 Filed May 12, 2021 17:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 4,934 | $5.94 | $29,307.96 |
DisclosureSEC source: 0001576280-21-000064 · wf-form4_162085450202125.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 18:06 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 4,934 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001576280-21-000040 · wf-form4_161843795575355.xml · derivative · entry 7 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,143 Underlying: COMMON STOCK · 4,934 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 18:06 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 210 | $156.59 | $32,883.21 |
DisclosureSEC source: 0001576280-21-000040 · wf-form4_161843795575355.xml · nonDerivative · entry 6 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.12 to $156.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 18:06 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 940 | $155.46 | $146,136.07 |
DisclosureSEC source: 0001576280-21-000040 · wf-form4_161843795575355.xml · nonDerivative · entry 5 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,269 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.11 to $156.015, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 18:06 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 1,584 | $154.47 | $244,676.68 |
DisclosureSEC source: 0001576280-21-000040 · wf-form4_161843795575355.xml · nonDerivative · entry 4 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,209 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $154.055 to $155.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 18:06 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 594 | $152.99 | $90,875.58 |
DisclosureSEC source: 0001576280-21-000040 · wf-form4_161843795575355.xml · nonDerivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,793 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.76 to $153.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 18:06 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 1,606 | $151.91 | $243,961.36 |
DisclosureSEC source: 0001576280-21-000040 · wf-form4_161843795575355.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,387 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.71 to $152.305, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 18:06 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 4,934 | $5.94 | $29,307.96 |
DisclosureSEC source: 0001576280-21-000040 · wf-form4_161843795575355.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 17:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 4,934 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001576280-21-000036 · wf-form4_161558788138652.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,077 Underlying: COMMON STOCK · 4,934 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 17:25 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 4,934 | $137.85 | $680,151.90 |
DisclosureSEC source: 0001576280-21-000036 · wf-form4_161558788138652.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 17:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 4,934 | $5.94 | $29,307.96 |
DisclosureSEC source: 0001576280-21-000036 · wf-form4_161558788138652.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 01:37 UTC | DoorDash, Inc. DASH · Entity 1541 | OtherClass A Common Stock | 440 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-019996 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 440 F1 · kind: Represents the receipt of shares of Class A Common Stock of the Issuer by virtue of the pro rata in-kind distribution by KPCB Digital Growth Fund II, LLC. F2 · ownership.nature: Shares are held by the Meresman Family Trust for which the Reporting Person and his spouse serve as trustees. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:30 UTC | Cloudflare, Inc. NET · Entity 2910 | ConversionClass B Common Stock · Derivative | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011983 · doc4.xml · derivative · entry 8 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 24,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:30 UTC | Cloudflare, Inc. NET · Entity 2910 | Exercise / conversionClass B Common Stock · Derivative | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011983 · doc4.xml · derivative · entry 7 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Class A Common Stock · 24,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:30 UTC | Cloudflare, Inc. NET · Entity 2910 | Exercise / conversionStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $8.56 | $0.00 |
DisclosureSEC source: 0001209191-21-011983 · doc4.xml · derivative · entry 6 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,000 Underlying: Class B Common Stock · 24,000 shares Expires 2028-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 16 equal quarterly installments following December 13, 2018. F1 · derivative.underlying: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:30 UTC | Cloudflare, Inc. NET · Entity 2910 | SaleClass A Common Stock | 3,465 | $84.58 | $293,075.59 |
DisclosureSEC source: 0001209191-21-011983 · doc4.xml · nonDerivative · entry 5 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,622 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.49 to $84.77, inclusive. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:30 UTC | Cloudflare, Inc. NET · Entity 2910 | SaleClass A Common Stock | 3,690 | $83.99 | $309,911.29 |
DisclosureSEC source: 0001209191-21-011983 · doc4.xml · nonDerivative · entry 4 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,087 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.46 to $84.25, inclusive. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:30 UTC | Cloudflare, Inc. NET · Entity 2910 | SaleClass A Common Stock | 4,322 | $82.74 | $357,581.97 |
DisclosureSEC source: 0001209191-21-011983 · doc4.xml · nonDerivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,777 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.46 to $83.43, inclusive. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:30 UTC | Cloudflare, Inc. NET · Entity 2910 | SaleClass A Common Stock | 12,523 | $82.19 | $1,029,230.31 |
DisclosureSEC source: 0001209191-21-011983 · doc4.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,099 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.45 to $82.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (6) to this Form 4. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:30 UTC | Cloudflare, Inc. NET · Entity 2910 | ConversionClass A Common Stock | 24,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-011983 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 16:53 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 4,934 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001576280-21-000015 · wf-form4_161316677297134.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,011 Underlying: COMMON STOCK · 4,934 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 16:53 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 4,934 | $162.71 | $802,811.14 |
DisclosureSEC source: 0001576280-21-000015 · wf-form4_161316677297134.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 16:53 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 4,934 | $5.94 | $29,307.96 |
DisclosureSEC source: 0001576280-21-000015 · wf-form4_161316677297134.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2021 Filed Jan 26, 2021 19:42 UTC | Medallia, Inc. MDLA · Entity 133980 | SaleCommon Stock | 80,000 | $41.98 | $3,358,792.00 |
DisclosureSEC source: 0001246360-21-000179 · form.xml · nonDerivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Cassie H. Meresman Heritage Trust Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person on June 17, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.97 to $42.30, inclusive. F5 · ownership.nature: The shares are held of record by the Cassie H. Meresman Heritage Trust dated October 13, 2003 for which the reporting person serves as a trustee. Read SEC document |
| January 26, 2021 Filed Jan 26, 2021 19:42 UTC | Medallia, Inc. MDLA · Entity 133980 | SaleCommon Stock | 80,000 | $41.98 | $3,358,288.00 |
DisclosureSEC source: 0001246360-21-000179 · form.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Meresman Family Trust Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person on June 17, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.97 to $42.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4. F3 · ownership.nature: The shares are held of record by the Meresman Family Trust U/D/T dated 9/13/89 for which the reporting person serves as a trustee. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 16:40 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 4,934 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001576280-21-000007 · wf-form4_161057399562378.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,945 Underlying: COMMON STOCK · 4,934 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 16:40 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 4,934 | $142.00 | $700,628.00 |
DisclosureSEC source: 0001576280-21-000007 · wf-form4_161057399562378.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 16:40 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 4,934 | $5.94 | $29,307.96 |
DisclosureSEC source: 0001576280-21-000007 · wf-form4_161057399562378.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2020 Filed Dec 17, 2020 16:49 UTC | Medallia, Inc. MDLA · Entity 133980 | SaleCommon Stock | 7,500 | $35.01 | $262,559.25 |
DisclosureSEC source: 0001246360-20-001965 · form.xml · nonDerivative · entry 4 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Cassie H. Meresman Heritage Trust Disclosed balance after: 80,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person on June 17, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.67 to $35.31, inclusive. F3 · ownership.nature: The shares are held of record by the Cassie H. Meresman Heritage Trust dated October 13, 2003 for which the reporting person serves as a trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.